These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25244401)

  • 1. Pronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbits.
    Ziupa D; Beck J; Franke G; Perez Feliz S; Hartmann M; Koren G; Zehender M; Bode C; Brunner M; Odening KE
    PLoS One; 2014; 9(9):e107210. PubMed ID: 25244401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits.
    Odening KE; Jung BA; Lang CN; Cabrera Lozoya R; Ziupa D; Menza M; Relan J; Franke G; Perez Feliz S; Koren G; Zehender M; Bode C; Brunner M; Sermesant M; Föll D
    Heart Rhythm; 2013 Oct; 10(10):1533-41. PubMed ID: 23892340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicorandil normalizes prolonged repolarisation in the first transgenic rabbit model with Long-QT syndrome 1 both in vitro and in vivo.
    Biermann J; Wu K; Odening KE; Asbach S; Koren G; Peng X; Zehender M; Bode C; Brunner M
    Eur J Pharmacol; 2011 Jan; 650(1):309-16. PubMed ID: 20959120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization.
    Odening KE; Hyder O; Chaves L; Schofield L; Brunner M; Kirk M; Zehender M; Peng X; Koren G
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2264-72. PubMed ID: 18835916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Long Heart Rate Variation Increases Dispersion of Action Potential Duration in Long QT Type 2 Transgenic Rabbit Model.
    Kim TY; Jeng P; Hwang J; Pfeiffer Z; Patel D; Cooper LL; Kossidas K; Centracchio J; Peng X; Koren G; Qu Z; Choi BR
    Sci Rep; 2019 Oct; 9(1):14849. PubMed ID: 31619700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.
    Bentzen BH; Bahrke S; Wu K; Larsen AP; Odening KE; Franke G; Storm vańs Gravesande K; Biermann J; Peng X; Koren G; Zehender M; Bode C; Grunnet M; Brunner M
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):223-30. PubMed ID: 21135701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electro-mechanical (dys-)function in long QT syndrome type 1.
    Ziupa D; Menza M; Koppermann S; Moss R; Beck J; Franke G; Perez Feliz S; Brunner M; Mayer S; Bugger H; Koren G; Zehender M; Jung BA; Seemann G; Foell D; Bode C; Odening KE
    Int J Cardiol; 2019 Jan; 274():144-151. PubMed ID: 30017522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction.
    Odening KE; Kirk M; Brunner M; Ziv O; Lorvidhaya P; Liu GX; Schofield L; Chaves L; Peng X; Zehender M; Choi BR; Koren G
    Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H643-55. PubMed ID: 20581090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential conditions for early after-depolarizations and triggered activity in cardiomyocytes derived from transgenic LQT1 and LQT2 rabbits.
    Liu GX; Choi BR; Ziv O; Li W; de Lange E; Qu Z; Koren G
    J Physiol; 2012 Mar; 590(5):1171-80. PubMed ID: 22183728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatially Discordant Alternans and Arrhythmias in Tachypacing-Induced Cardiac Myopathy in Transgenic LQT1 Rabbits: The Importance of IKs and Ca2+ Cycling.
    Lau E; Kossidas K; Kim TY; Kunitomo Y; Ziv O; Song Z; Taylor C; Schofield L; Yammine J; Liu G; Peng X; Qu Z; Koren G; Choi BR
    PLoS One; 2015; 10(5):e0122754. PubMed ID: 25970695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid normalizes QT interval in long QT type 2 transgenic rabbit models in a genotype-specific fashion.
    Castiglione A; Hornyik T; Wülfers EM; Giammarino L; Edler I; Jowais JJ; Rieder M; Perez-Feliz S; Koren G; Bősze Z; Varró A; Zehender M; Brunner M; Bode C; Liin SI; Larsson HP; Baczkó I; Odening KE
    Europace; 2022 Mar; 24(3):511-522. PubMed ID: 34601592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous distribution of the two components of delayed rectifier K+ current: a potential mechanism of the proarrhythmic effects of methanesulfonanilideclass III agents.
    Cheng J; Kamiya K; Liu W; Tsuji Y; Toyama J; Kodama I
    Cardiovasc Res; 1999 Jul; 43(1):135-47. PubMed ID: 10536698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
    Guérard NC; Traebert M; Suter W; Dumotier BM
    J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndrome.
    Frommeyer G; Krawczyk J; Ellermann C; Bögeholz N; Kochhäuser S; Dechering DG; Fehr M; Eckardt L
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):471-476. PubMed ID: 29314443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
    Eur J Pharmacol; 2006 Dec; 553(1-3):229-39. PubMed ID: 17054943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia.
    Hondeghem LM; Dujardin K; De Clerck F
    Cardiovasc Res; 2001 May; 50(2):345-53. PubMed ID: 11334838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of complex behaviour of spatially discordant alternans in a transgenic rabbit model of type 2 long QT syndrome.
    Ziv O; Morales E; Song YK; Peng X; Odening KE; Buxton AE; Karma A; Koren G; Choi BR
    J Physiol; 2009 Oct; 587(Pt 19):4661-80. PubMed ID: 19675070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
    Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ
    Eur J Pharmacol; 2007 Dec; 577(1-3):222-32. PubMed ID: 18074444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
    Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.
    Odening KE; Bodi I; Franke G; Rieke R; Ryan de Medeiros A; Perez-Feliz S; Fürniss H; Mettke L; Michaelides K; Lang CN; Steinfurt J; Pantulu ND; Ziupa D; Menza M; Zehender M; Bugger H; Peyronnet R; Behrends JC; Doleschall Z; Zur Hausen A; Bode C; Jolivet G; Brunner M
    Eur Heart J; 2019 Mar; 40(10):842-853. PubMed ID: 30496390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.